Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.96B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.44B |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$2.36B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.95B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.62B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mercado Libre
MELI
|
+$899M |
| 2 |
Booking.com
BKNG
|
+$741M |
| 3 |
TAL Education Group
TAL
|
+$657M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$529M |
| 5 |
AT&T
T
|
+$475M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.18% |
| 2 | Healthcare | 10.51% |
| 3 | Financials | 7.84% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Communication Services | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFYT
3626
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $1.34M | ﹤0.01% |
59,836
-2,624
| -4% | -$62.3K |
|
3627
Solid Biosciences
SLDB
$971M
| $1.34M | ﹤0.01% |
37,337
-8,938
| -19% | -$442K |
|
3628
WisdomTree Enhanced Commodity Strategy Fund
GCC
$281M
| $1.34M | ﹤0.01% |
92,482
+322
| +0.3% | +$5.52K |
|
|
APLS
3629
DELISTED
Apellis Pharmaceuticals
APLS
| $1.33M | ﹤0.01% |
49,660
-72,887
| -59% | -$2.59M |
|
|
MLPI
3630
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
| $1.33M | ﹤0.01% |
163,427
-525,013
| -76% | -$8.08M |
|
|
ENX
3631
DELISTED
Eaton Vance New York Municipal Bond Fund
ENX
| $1.33M | ﹤0.01% |
114,896
+3,549
| +3% | +$42.9K |
|
|
CCXI
3632
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.33M | ﹤0.01% |
33,073
-58,685
| -64% | -$2.49M |
|
|
PFL
3633
PIMCO Income Strategy Fund
PFL
$384M
| $1.33M | ﹤0.01% |
157,115
-1,906
| -1% | -$21K |
|
|
ARCE
3634
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $1.32M | ﹤0.01% |
31,318
-120,364
| -79% | -$5.96M |
|
3635
Planet Fitness
PLNT
$3.81B
| $1.32M | ﹤0.01% |
27,156
-14,704
| -35% | -$1.03M |
|
|
SCX
3636
DELISTED
The L.S. Starrett Company
SCX
| $1.32M | ﹤0.01% |
408,162
+186
| +0% | +$901 |
|
3637
Greif
GEF
$4.99B
| $1.32M | ﹤0.01% |
42,379
-40,936
| -49% | -$1.55M |
|
|
AVDL
3638
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.31M | ﹤0.01% |
165,588
-563,701
| -77% | -$4.33M |
|
3639
HCI Group
HCI
$2.3B
| $1.31M | ﹤0.01% |
32,554
-24,436
| -43% | -$1.05M |
|
3640
Sprout Social
SPT
$599M
| $1.31M | ﹤0.01% |
82,038
+79,184
| +2,774% | +$1.44M |
|
3641
Delek US
DK
$4.07B
| $1.3M | ﹤0.01% |
82,706
-121,719
| -60% | -$2.89M |
|
3642
Larimar Therapeutics
LRMR
$445M
| $1.3M | ﹤0.01% |
141,267
-446
| -0.3% | -$5.86K |
|
|
CMO
3643
DELISTED
Capstead Mortgage Corp.
CMO
| $1.3M | ﹤0.01% |
310,539
-350,928
| -53% | -$2.5M |
|
3644
TechTarget
TTGT
$276M
| $1.3M | ﹤0.01% |
63,244
-62,895
| -50% | -$1.49M |
|
|
CHX
3645
DELISTED
ChampionX
CHX
| $1.3M | ﹤0.01% |
226,074
+109,186
| +93% | +$2.27M |
|
3646
Cannae Holdings
CNNE
$652M
| $1.3M | ﹤0.01% |
38,837
-69,211
| -64% | -$2.57M |
|
|
NRT
3647
North European Oil Royalty Trust
NRT
$85.4M
| $1.3M | ﹤0.01% |
494,667
-24,892
| -5% | -$108K |
|
3648
United Parks & Resorts
PRKS
$2.05B
| $1.3M | ﹤0.01% |
117,937
-297,211
| -72% | -$8.14M |
|
3649
Cohu
COHU
$2.75B
| $1.3M | ﹤0.01% |
104,927
-92,329
| -47% | -$1.88M |
|
3650
Enovis
ENOV
$1.52B
| $1.3M | ﹤0.01% |
38,069
-479
| -1% | -$26.3K |
|
Similar funds
Morgan Stanley's Q1 2020 Portfolio in Review
As of Q1 2020, Morgan Stanley held 6,975 positions worth $368B, down 14% from $430B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley deployed $22.6B of net new capital in Q1 2020, opening 179 new positions and adding to 2,114 existing holdings. Its largest new stake was Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares): 3,933,816 shares worth $38.7M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Mercado Libre, an estimated $899M trimmed.
- Morgan Stanley's largest Q1 2020 buy was Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares): 3,933,816 shares worth $38.7M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $3.96B increase.
- Morgan Stanley's biggest Q1 2020 reduction was Mercado Libre, cutting an estimated $899M.
- Morgan Stanley fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $124M.
- Morgan Stanley's ten largest holdings make up 17% of its $368B portfolio in Q1 2020.
- Morgan Stanley opened 179 new positions and closed 220 in Q1 2020.
- Morgan Stanley's portfolio value fell 14% quarter-over-quarter to $368B.
Based on Morgan Stanley's 13F filing for Q1 2020, filed 15 May 2020.